Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
helicobacter pylori (46) 46
humans (41) 41
gastroenterology & hepatology (38) 38
helicobacter infections - drug therapy (32) 32
index medicus (29) 29
treatment outcome (26) 26
eradication (24) 24
helicobacter pylori - drug effects (24) 24
anti-bacterial agents - therapeutic use (20) 20
adult (19) 19
aged (18) 18
clarithromycin (18) 18
drug therapy, combination (18) 18
female (18) 18
male (18) 18
middle aged (18) 18
triple therapy (18) 18
helicobacter infections - microbiology (17) 17
infection (17) 17
helicobacter (16) 16
antibiotic-resistance (15) 15
helicobacter infections - diagnosis (15) 15
pylori (15) 15
metronidazole (14) 14
topic highlight (13) 13
anti-bacterial agents - administration & dosage (12) 12
clarithromycin - therapeutic use (12) 12
drug resistance, bacterial (12) 12
amoxicillin (11) 11
helicobacter infections (11) 11
omeprazole (11) 11
helicobacter pylori - isolation & purification (10) 10
pharmacology & pharmacy (10) 10
resistance (10) 10
amoxicillin - therapeutic use (9) 9
antibiotic resistance (9) 9
antibiotics (9) 9
amoxicillin - administration & dosage (8) 8
clarithromycin - administration & dosage (8) 8
drug administration schedule (8) 8
helicobacter pylori - pathogenicity (8) 8
microbial sensitivity tests (8) 8
proton pump inhibitors - therapeutic use (8) 8
sequential therapy (8) 8
therapy (8) 8
anti-ulcer agents - therapeutic use (7) 7
clarithromycin resistance (7) 7
consensus report (7) 7
drug resistance (7) 7
metronidazole - therapeutic use (7) 7
mutation (7) 7
polymerase chain reaction (7) 7
rescue therapy (7) 7
treatment (7) 7
adolescent (6) 6
drug resistance in microorganisms (6) 6
efficacy (6) 6
levofloxacin (6) 6
metronidazole - administration & dosage (6) 6
microbiology (6) 6
proton-pump inhibitor (6) 6
quadruple therapy (6) 6
2-pyridinylmethylsulfinylbenzimidazoles (5) 5
aged, 80 and over (5) 5
analysis (5) 5
antimicrobial resistance (5) 5
bacterial infections and mycoses (5) 5
biopsy (5) 5
clarithromycin - pharmacology (5) 5
diagnosis (5) 5
duodenal-ulcer (5) 5
gastritis - drug therapy (5) 5
gastritis - microbiology (5) 5
health aspects (5) 5
helicobacter infections - therapy (5) 5
helicobacter pylori - genetics (5) 5
management (5) 5
metronidazole resistance (5) 5
omeprazole - administration & dosage (5) 5
omeprazole - analogs & derivatives (5) 5
omeprazole - therapeutic use (5) 5
treatment failure (5) 5
animals (4) 4
anti-bacterial agents - adverse effects (4) 4
antibiotic (4) 4
antiulcer drugs (4) 4
bismuth (4) 4
care and treatment (4) 4
concomitant therapy (4) 4
drug resistance, bacterial - genetics (4) 4
drug resistance, microbial (4) 4
duodenal ulcer - microbiology (4) 4
duodenal-ulcer patients (4) 4
dyspepsia (4) 4
gastroenterology (4) 4
helicobacter infections - epidemiology (4) 4
helicobacter infections - pathology (4) 4
high prevalence (4) 4
in-vitro (4) 4
methods (4) 4
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second‐line treatment of resistant Helicobacter pylori infection
by WONG, W. M and GU, Q and CHU, K.‐M and YEE, Y. K and FUNG, F. M. Y and TONG, T. S. M and CHAN, A. O. O and LAI, K. C and CHAN, C. K and WONG, B. C. Y
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 02/2006, Volume 23, Issue 3, pp. 421 - 427
Summary Aim To test the efficacy of levofloxacin‐based second‐line therapy for resistant Helicobacter pylori infection. Methods One hundred and six patients... 
DUODENAL-ULCER | OMEPRAZOLE | RANITIDINE BISMUTH CITRATE | PHARMACOLOGY & PHARMACY | ERADICATION | TETRACYCLINE | METRONIDAZOLE RESISTANCE | GASTROENTEROLOGY & HEPATOLOGY | HIGH PREVALENCE | HONG-KONG | FAILURE | RESCUE THERAPY | Levofloxacin | Omeprazole - therapeutic use | Hong Kong | Humans | Middle Aged | Tetracycline - therapeutic use | Anti-Infective Agents - therapeutic use | Drug Resistance, Bacterial | Ofloxacin - therapeutic use | Male | Treatment Outcome | Organometallic Compounds | Anti-Bacterial Agents - therapeutic use | Helicobacter pylori | Metronidazole - therapeutic use | Helicobacter Infections - drug therapy | Amoxicillin - therapeutic use | 2-Pyridinylmethylsulfinylbenzimidazoles | Adult | Female | Aged | Drug Therapy, Combination | Lansoprazole | Omeprazole - analogs & derivatives | Health aspects | Amoxicillin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxycillin in vitro and in clinical treatment in Japan
by MIYAJI, H and AZUMA, T and ITO, S and SUTO, H and ITO, Y and YAMAZAKI, Y and SATO, F and HIRAI, M and KURIYAMA, M and KATO, T and KOHLI, Y
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 11/1997, Volume 11, Issue 6, pp. 1131 - 1136
Background: Primary and acquired resistance to antibiotics is an important factor in determining the reason for treatment failure in Helicobacter pylori... 
COLLOIDAL BISMUTH SUBCITRATE | DUODENAL-ULCER | CAMPYLOBACTER-PYLORI | DISEASE | RESISTANCE | OMEPRAZOLE | TRIPLE THERAPY | PHARMACOLOGY & PHARMACY | ERADICATION | INFECTION | CURE | GASTROENTEROLOGY & HEPATOLOGY | Disease Susceptibility | Proton Pump Inhibitors | Humans | Japan | Middle Aged | Treatment Outcome | Clarithromycin - therapeutic use | Drug Therapy, Combination - therapeutic use | Enzyme Inhibitors - therapeutic use | Microbial Sensitivity Tests | Drug Resistance, Microbial | Metronidazole - therapeutic use | Adolescent | Amoxicillin - therapeutic use | Aged, 80 and over | Adult | Aged | Helicobacter pylori - isolation & purification
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Fourteen-day optimized levofloxacin-based therapy versus classical quadruple therapy for Helicobacter pylori treatment failures: a randomized clinical trial
by Cao, Zhijun and Chen, Qi and Zhang, Wei and Liang, Xiao and Liao, Jingxian and Liu, Wenzhong and Xiao, Shudong and Lu, Hong
Scandinavian Journal of Gastroenterology, ISSN 0036-5521, 10/2015, Volume 50, Issue 10, pp. 1185 - 1190
Objective. To test the efficacy of lansoprazole, bismuth, levofloxacin, and amoxicillin therapy compared to bismuth metronidazole tetracycline (BMT) quadruple... 
drug therapy | quadruple therapy | Helicobacter pylori | levofloxacin | bismuth | ANTIBIOTICS | EFFICACY | CHINA | 2ND-LINE | RESISTANCE | TRIPLE THERAPY | INFECTION | ERADICATION | GASTROENTEROLOGY & HEPATOLOGY | Immunohistochemistry | Bismuth - administration & dosage | Gastric Mucosa - microbiology | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Helicobacter pylori - drug effects | Male | Dose-Response Relationship, Drug | Young Adult | Helicobacter Infections - drug therapy | Treatment Failure | Adult | Female | Amoxicillin - administration & dosage | Helicobacter Infections - diagnosis | Drug Therapy, Combination | Levofloxacin - administration & dosage | Lansoprazole - administration & dosage | Gastroscopy - methods | Drug Administration Schedule | Administration, Oral | Metronidazole - administration & dosage | Treatment Outcome | Aged | Helicobacter pylori - isolation & purification | Biopsy, Needle
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Helicobacter pylori eradication rates with concomitant and tailored therapy based on 23S rRNA point mutation: A multicenter randomized controlled trial
by Ong, Sungmoon and Kim, Sung Eun and Kim, Ji Hyun and Yi, Nam Hee and Kim, Tae Young and Jung, Kyoungwon and Park, Moo In and Jung, Hwoon‐Yong
Helicobacter, ISSN 1083-4389, 10/2019, Volume 24, Issue 5, pp. e12654 - n/a
Background We evaluated the efficacy of tailored therapy based on point mutation presence identified with the dual‐priming oligonucleotide (DPO)‐based... 
concomitant therapy | tailored therapy | eradication | point mutation | STRAINS | ANTIBIOTIC-RESISTANCE | MICROBIOLOGY | OPEN-LABEL | CLARITHROMYCIN-RESISTANT | KOREA | ANTIMICROBIAL RESISTANCE | TRIPLE THERAPY | BISMUTH QUADRUPLE | INFECTION | METRONIDAZOLE | GASTROENTEROLOGY & HEPATOLOGY | Multiplexing | Therapy | Clarithromycin | Yeast | rRNA | rRNA 23S | Priming | Polymerase chain reaction | Motivation | Helicobacter pylori | Amoxicillin | Point mutation | Mutation | Metronidazole
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Furazolidone-based triple and quadruple eradication therapy for Helicobacter pylori infection
by Yong Xie Yin Zhu Hong Zhou Zhi-Fa Lu Zhen Yang Xu Shu Xiao-Bai Guo Hui-Zhen Fan Jian-Hua Tang Xue-Ping Zeng Jian-Bo Wen Xiao-Qing Li Xing-Xing He Jiu-Hong Ma Dong-Sheng Liu Cai-Bin Huang Ning-Jian Xu Nong-Rong Wang Nong-Hua Lu
世界胃肠病学杂志：英文版（电子版）, ISSN 1007-9327, 2014, Volume 20, Issue 32, pp. 11415 - 11421
AIM: To evaluate the efficacy of furazolidone-based triple and quadruple therapy in eradicating Helicobacter pylori(H. pylori) in a multi-center randomized... 
pylori | infection | Furazolidone | Treatme | Helicobacter | Helicobacter pylori infection | Treatment | Eradication | CLARITHROMYCIN | CONTROLLED-TRIAL | RABEPRAZOLE | MANAGEMENT | ANTIBIOTIC-RESISTANCE | SEQUENTIAL THERAPY | BISMUTH | CONSENSUS REPORT | LEVOFLOXACIN | METRONIDAZOLE | GASTROENTEROLOGY & HEPATOLOGY | Rabeprazole - therapeutic use | Humans | Middle Aged | Helicobacter pylori - pathogenicity | Furazolidone - administration & dosage | Duodenal Ulcer - diagnosis | Helicobacter pylori - drug effects | Male | Furazolidone - therapeutic use | Furazolidone - adverse effects | Anti-Bacterial Agents - therapeutic use | Time Factors | China | Helicobacter Infections - drug therapy | Organometallic Compounds - therapeutic use | Adult | Female | Anti-Bacterial Agents - adverse effects | Helicobacter Infections - diagnosis | Drug Therapy, Combination | Drug Administration Schedule | Treatment Outcome | Proton Pump Inhibitors - therapeutic use | Duodenal Ulcer - microbiology | Amoxicillin - therapeutic use | Intention to Treat Analysis | Duodenal Ulcer - drug therapy | Anti-Bacterial Agents - administration & dosage | Helicobacter Infections - microbiology | Randomized Clinical Trial
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies
by Perri, F and Festa, V and Clemente, R and Villani, MR and Quitadamo, M and Caruso, N and Li Bergoli, M and Andriulli, A
AMERICAN JOURNAL OF GASTROENTEROLOGY, ISSN 0002-9270, 01/2001, Volume 96, Issue 1, pp. 58 - 62
OBJECTIVES: A novel rifabutin-based therapy is able to cure Helicobacter pylori infection in most patients who have failed eradication after standard proton... 
CLARITHROMYCIN | OMEPRAZOLE | RESISTANCE | ERADICATION THERAPY | TETRACYCLINE | RETREATMENT | METRONIDAZOLE | GASTROENTEROLOGY & HEPATOLOGY | AMOXICILLIN | REGIMENS | Confidence Intervals | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Helicobacter pylori - drug effects | Male | Rifabutin - administration & dosage | Enzyme Inhibitors - administration & dosage | Sulfoxides - administration & dosage | Benzimidazoles - administration & dosage | Helicobacter Infections - drug therapy | Treatment Failure | Gastritis - microbiology | Adult | Female | Amoxicillin - administration & dosage | Helicobacter Infections - diagnosis | Drug Therapy, Combination | Gastritis - drug therapy | Drug Administration Schedule | Metronidazole - administration & dosage | Probability | Gastroscopy | 2-Pyridinylmethylsulfinylbenzimidazoles | Aged | Helicobacter pylori - isolation & purification | Biopsy, Needle | Anti-Bacterial Agents - administration & dosage | Tetracycline - administration & dosage | Omeprazole - analogs & derivatives | Organometallic Compounds - administration & dosage
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text H pylori antibiotic resistance: prevalence, importance, and advances in testing
by Mégraud, F
Gut, ISSN 0017-5749, 09/2004, Volume 53, Issue 9, pp. 1374 - 1384
  Table 1 Primary resistance of Helicobacter pylori to clarithromycin, metronidazole, tetracycline, and amoxicillin in adults in different parts of the world... 
TRIPLE-THERAPY REGIMENS | 23S RIBOSOMAL-RNA | IN-SITU HYBRIDIZATION | ANTIMICROBIAL-SUSCEPTIBILITY | RANITIDINE BISMUTH CITRATE | MACROLIDE RESISTANCE | FRAGMENT LENGTH POLYMORPHISM | DUODENAL-ULCER PATIENTS | METRONIDAZOLE RESISTANCE | GASTROENTEROLOGY & HEPATOLOGY | CLARITHROMYCIN-RESISTANCE | Drug Resistance, Multiple, Bacterial | Helicobacter Infections - drug therapy | Humans | Drug Resistance, Bacterial | Adult | Helicobacter pylori - drug effects | Clarithromycin - pharmacology | Drug Therapy, Combination - pharmacology | Microbial Sensitivity Tests - methods | Helicobacter Infections - microbiology | Drug resistance in microorganisms | Research | Helicobacter pylori | Gastroenterology | Studies | Confidence intervals | Antibiotics | Ulcers | Bacteria | Mutation | Drug resistance | Methods | metronidazole | Recent Advances in Clinical Practice | clarithromycin | antibiotic resistance
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Treatment of Helicobacter pylori Infection: A Review of the World Literature
by Der Hulst, René W.M and Keller, Josbert J and Rauws, Erik A.J and Tytgat, Guido N.J
Helicobacter, ISSN 1083-4389, 03/1996, Volume 1, Issue 1, pp. 6 - 19
ABSTRACT Background.None of the currently used anti‐Helicobacter pylori drug regimens cures the infection 100%, and cure results still vary considerably. The... 
Smoking - adverse effects | Bismuth - administration & dosage | Humans | Helicobacter pylori - drug effects | Bismuth - therapeutic use | Antacids - therapeutic use | Metronidazole - therapeutic use | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Gastritis - microbiology | Amoxicillin - administration & dosage | Gastritis - drug therapy | Omeprazole - therapeutic use | Drug Administration Schedule | Proton Pump Inhibitors | Metronidazole - administration & dosage | Omeprazole - administration & dosage | Enzyme Inhibitors - pharmacology | Tetracycline - therapeutic use | Treatment Outcome | Clarithromycin - therapeutic use | Drug Therapy, Combination - therapeutic use | Enzyme Inhibitors - therapeutic use | Drug Resistance, Microbial | Drug Therapy, Combination - administration & dosage | Amoxicillin - therapeutic use | Antacids - administration & dosage | Tetracycline - administration & dosage
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Systematic review: Would susceptibility‐guided treatment achieve acceptable cure rates for second‐line Helicobacter pylori therapy as currently practiced?
by Baylina, Mireia and Muñoz, Neus and Sánchez‐Delgado, Jordi and López‐Góngora, Sheila and Calvet, Xavier and Puig, Ignasi
Helicobacter, ISSN 1083-4389, 06/2019, Volume 24, Issue 3, pp. e12584 - n/a
Background Susceptibility‐guided treatment has been proposed as a way to improve Helicobacter pylori eradication rates. Evidence on its efficacy for rescue... 
culture‐guided treatment | resistances | Helicobacter pylori | second‐line treatments | CONTAINING TRIPLE-THERAPY | RABEPRAZOLE | EFFICACY | PROTON-PUMP INHIBITOR | second-line treatments | MICROBIOLOGY | FAILURE | culture-guided treatment | QUADRUPLE THERAPY | AMOXICILLIN-METRONIDAZOLE | INFECTION | ERADICATION | GASTROENTEROLOGY & HEPATOLOGY | RESCUE THERAPY | Anti-Bacterial Agents - therapeutic use | Metronidazole - therapeutic use | Helicobacter Infections - drug therapy | Humans | Amoxicillin - therapeutic use | Levofloxacin - therapeutic use | Helicobacter pylori - drug effects | Treatment Outcome | Clarithromycin - therapeutic use | Endoscopy | Helicobacter Infections - microbiology | Medical research | Medicine, Experimental | Metronidazole | Antibacterial agents | Antiulcer drugs | Therapy | Levofloxacin | Clarithromycin | Clinical trials | Systematic review | Patients | Endoscopes | Antibiotics | Acceptance tests | Culture
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Meta‐analysis: Helicobacter pylori eradication treatment efficacy in children
by KHURANA, R and FISCHBACH, L and CHIBA, N and VAN ZANTEN, S. V and SHERMAN, P. M and GEORGE, B. A and GOODMAN, K. J and GOLD, B. D
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 03/2007, Volume 25, Issue 5, pp. 523 - 536
Summary Background  Several meta‐analyses assessing the efficacy of anti‐Helicobacter pylori treatment in adults have been published but a comparable... 
COLLOIDAL BISMUTH SUBCITRATE | TREATMENT SCHEDULES | DYSPEPTIC CHILDREN | PEDIATRIC-PATIENTS | RECURRENT ABDOMINAL-PAIN | TERM-FOLLOW-UP | TRIPLE THERAPY | PHARMACOLOGY & PHARMACY | IRON-DEFICIENCY ANEMIA | PLACEBO-CONTROLLED TRIAL | GASTROENTEROLOGY & HEPATOLOGY | PEPTIC-ULCER DISEASE | Anti-Bacterial Agents - therapeutic use | Helicobacter Infections - drug therapy | Humans | Adolescent | Child, Preschool | Adult | Helicobacter pylori - drug effects | Infant | Treatment Outcome | Drug Therapy, Combination | Child | Infant, Newborn | Pediatric pharmacology | Children | Helicobacter pylori | Analysis | Amoxicillin
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Efficacy and safety of rifabutin‐containing ‘rescue therapy’ for resistant Helicobacter pylori infection
by BORODY, T. J and PANG, G and WETTSTEIN, A. R and CLANCY, R and HERDMAN, K and SURACE, R and LLORENTE, R and NG, C
Alimentary Pharmacology & Therapeutics, ISSN 0269-2813, 02/2006, Volume 23, Issue 4, pp. 481 - 488
Summary Background  Current ‘rescue’ therapies provide inadequate Helicobacter pylori eradication rates because of antibiotic resistance. Aim  To test the... 
CLARITHROMYCIN | QUADRUPLE THERAPY | TREATMENT FAILURES | OMEPRAZOLE | TRIPLE THERAPY | PHARMACOLOGY & PHARMACY | ERADICATION | TETRACYCLINE | DUODENAL-ULCER PATIENTS | METRONIDAZOLE | GASTROENTEROLOGY & HEPATOLOGY | AMOXICILLIN | Prospective Studies | Sulfoxides - adverse effects | Humans | Middle Aged | Drug Resistance, Bacterial | Helicobacter pylori - drug effects | Male | Rifabutin - administration & dosage | Dose-Response Relationship, Drug | Microbial Sensitivity Tests | Sulfoxides - administration & dosage | Benzimidazoles - administration & dosage | Helicobacter Infections - drug therapy | Aged, 80 and over | Clarithromycin - administration & dosage | Adult | Female | Amoxicillin - administration & dosage | Anti-Bacterial Agents - adverse effects | Benzimidazoles - adverse effects | Drug Therapy, Combination | Drug Administration Schedule | Rifabutin - adverse effects | Metronidazole - administration & dosage | Omeprazole - administration & dosage | Anti-Ulcer Agents - adverse effects | Omeprazole - adverse effects | Treatment Outcome | Anti-Ulcer Agents - administration & dosage | 2-Pyridinylmethylsulfinylbenzimidazoles | Amoxicillin - adverse effects | Aged | Anti-Bacterial Agents - administration & dosage | Omeprazole - analogs & derivatives | Helicobacter pylori | Health aspects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Pretreatment Antimicrobial Susceptibility-Guided Vs. Clarithromycin-Based Triple Therapy for Helicobacter pylori Eradication in a Region With High Rates of Multiple Drug Resistance
by Park, Chung-Su and Lee, Su-Mi and Park, Chang-Hwan and Koh, Han-Ra and Jun, Chung-Hwan and Park, Seon-Young and Lee, Wan-Sik and Joo, Young-Eun and Kim, Hyun-Soo and Choi, Sung-Kyu and Rew, Jong-Sun
American Journal of Gastroenterology, ISSN 0002-9270, 08/2014, Volume 109, Issue 10, pp. 1595 - 1602
OBJECTIVES: Helicobacter pylori eradication rates with clarithromycin-based triple therapy are declining, and an alternative strategy is needed urgently. We... 
ARTICLE | METAANALYSIS | GASTRIC-CANCER | ANTIBIOTIC-RESISTANCE | INFECTION | METRONIDAZOLE | GASTROENTEROLOGY & HEPATOLOGY | REGIMENS | Neoplasms, Glandular and Epithelial - pathology | Humans | Middle Aged | Male | Stomach Neoplasms - pathology | Helicobacter Infections - pathology | Neoplasms, Glandular and Epithelial - microbiology | Microbial Sensitivity Tests | Stomach Neoplasms - microbiology | Helicobacter pylori | Proton Pump Inhibitors - administration & dosage | Drug Resistance, Multiple, Bacterial | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Female | Aged | Amoxicillin - administration & dosage | Drug Therapy, Combination | Anti-Bacterial Agents - administration & dosage
Journal Article
Details down arrow
13. Full Text Helicobacter pylori eradication rates of concomitant and sequential therapies in Korea
by Kim, Seung Young and Lee, Sang Woo and Choe, Jung Wan and Jung, Sung Woo and Hyun, Jong Jin and Jung, Young Kul and Koo, Ja Seol and Yim, Hyung Joon
Helicobacter, ISSN 1083-4389, 12/2017, Volume 22, Issue 6, pp. e12441 - n/a
Background The efficacy of the standard triple therapy for Helicobacter pylori eradication has decreased to an unacceptable level. We aimed to compare the... 
sequential therapy | concomitant therapy | Helicobacter pylori | resistance | CLARITHROMYCIN | 1ST-LINE TREATMENT | MANAGEMENT | ANTIBIOTIC-RESISTANCE | RANDOMIZED-TRIAL | MICROBIOLOGY | OPEN-LABEL | CONSENSUS REPORT | TRIPLE THERAPY | INFECTION | GASTROENTEROLOGY & HEPATOLOGY | HYBRID THERAPY | Prospective Studies | Humans | Middle Aged | Drug Resistance, Bacterial | Male | Treatment Outcome | Clarithromycin - therapeutic use | Young Adult | Anti-Bacterial Agents - therapeutic use | Drug Therapy, Combination - methods | Helicobacter Infections - drug therapy | Adolescent | Aged, 80 and over | Adult | Female | Aged | Anti-Bacterial Agents - pharmacology | Helicobacter pylori - isolation & purification | Clarithromycin - pharmacology | Korea | Drug resistance in microorganisms | Helicobacter infections | Analysis | Amoxicillin | Antiulcer drugs | Multiplexing | Therapy | Clarithromycin | Sensitivity analysis | Effectiveness | Population studies | Priming | Patients | Polymerase chain reaction | Motivation | Metronidazole
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights